Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1211

1.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

Clin Ther. 2003 Nov;25(11):2958-71.

PMID:
14693318
2.

Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study.

Balkrishnan R, Bhosle MJ, Camacho FT, Anderson RT.

J Urol. 2006 Mar;175(3 Pt 1):1067-71; discussion 1071-2. Erratum in: J Urol. 2006 May;175(5):1967.

PMID:
16469620
4.

Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.

Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R.

J Glaucoma. 2007 Sep;16(6):513-20.

PMID:
17873711
5.
6.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
7.
8.

Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Whitmire JT, Anderson RT.

Curr Med Res Opin. 2004 Oct;20(10):1633-40. Erratum in: Curr Med Res Opin. 2005 Feb;21(2):323.

PMID:
15462696
9.

Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Anderson RT.

Curr Med Res Opin. 2006 Mar;22(3):551-9.

PMID:
16574038
10.

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9.

PMID:
17157128
11.

Medication and health care service utilization related to depressive symptoms in older adults with psoriasis.

Kulkarni AS, Balkrishnan R, Camacho FT, Anderson RT, Feldman SR.

J Drugs Dermatol. 2004 Nov-Dec;3(6):661-6.

PMID:
15624749
12.

Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma.

Balkrishnan R, Christensen DB, Bowton DL.

J Am Geriatr Soc. 2002 May;50(5):924-9.

PMID:
12028182
13.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
14.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
15.
16.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007;29 Spec No:1306-15.

PMID:
18046930
17.

Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.

Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.

Ann Pharmacother. 2011 Mar;45(3):342-9. doi: 10.1345/aph.1P539. Epub 2011 Feb 15.

PMID:
21325098
18.

Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.

Bhosle MJ, Reardon G, Camacho FT, Anderson RT, Balkrishnan R.

Am J Geriatr Pharmacother. 2007 Jun;5(2):100-11.

PMID:
17719512
19.
20.

Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus.

Brown JB, Nichols GA, Glauber HS, Bakst AW, Schaeffer M, Kelleher CC.

Am J Health Syst Pharm. 2001 Jan 15;58(2):151-7.

PMID:
11202539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk